Received May 26, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | P5SR5 | — |
an expired Boostrix was given to a patient this week on 20-May-2026; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 86-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number P5SR5, expiry date 26-APR-2026) for prophylaxis. On 20-MAY-2026, the patient received Boostrix. On 20-MAY-2026, an unknown time after receiving Boostrix, the patient experienced expired vaccine used (Verbatim: an expired Boostrix was given to a patient this week on 20-May-2026). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.; Sender's Comments: US-GSK-US2026069418:Same reporter/Diffrent patient